Cargando…
Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers
Targeted radionuclide therapy (TRT) is a promising strategy to treat different types of cancer. TRT relies on a targeting vector used to deliver a therapeutic radionuclide specifically to the tumour site. Several low molecular weight ligands targeting the prostate-specific membrane antigen (PSMA) ha...
Autores principales: | Murce, Erika, de Blois, Erik, van den Berg, Sophie, de Jong, Marion, Seimbille, Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993039/ https://www.ncbi.nlm.nih.gov/pubmed/36908985 http://dx.doi.org/10.1098/rsos.220950 |
Ejemplares similares
-
Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
por: Trachsel, Belinda, et al.
Publicado: (2023) -
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
por: Murce, Erika, et al.
Publicado: (2023) -
Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics
por: Murce, Erika, et al.
Publicado: (2023) -
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
por: Murce, Erika, et al.
Publicado: (2023) -
Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021)